145 related articles for article (PubMed ID: 8443764)
21. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
Baak JP; Chin D; van Diest PJ; Ortiz R; Matze-Cok P; Bacus SS
Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of flow cytometric DNA analysis in node-negative breast cancer patients.
Lewis WE
Cancer; 1990 May; 65(10):2315-20. PubMed ID: 2346915
[TBL] [Abstract][Full Text] [Related]
23. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients.
Wenger CR; Beardslee S; Owens MA; Pounds G; Oldaker T; Vendely P; Pandian MR; Harrington D; Clark GM; McGuire WL
Breast Cancer Res Treat; 1993 Oct; 28(1):9-20. PubMed ID: 8123871
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric DNA analysis as prognostic factor in human breast carcinoma.
Ottestad L; Pettersen EO; Nesland JM; Hannisdal E; Fosså SD; Tveit KM
Pathol Res Pract; 1993 May; 189(4):405-10. PubMed ID: 8351241
[TBL] [Abstract][Full Text] [Related]
25. [Flow cytometric analysis of DNA ploidy pattern in breast cancer: malignant potential and prognostic implication].
Hara S; Tomita M
Nihon Rinsho; 1992 Oct; 50(10):2444-9. PubMed ID: 1447815
[TBL] [Abstract][Full Text] [Related]
26. Ploidy and S-phase fractions (SPF) of primary breast cancers and their nodal metastases.
Hupperets PS; Schutte B; van Assche C; Schouten LJ; Jager J; de Jong J; Blijham GH
Breast Cancer Res Treat; 1994; 32(2):197-202. PubMed ID: 7865849
[TBL] [Abstract][Full Text] [Related]
27. Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry.
Bergers E; van Diest PJ; Baak JP
J Clin Pathol; 1996 Nov; 49(11):931-7. PubMed ID: 8944615
[TBL] [Abstract][Full Text] [Related]
28. [DNA flow cytometric analysis in primary breast cancer. S-phase and ploidy status as prognostic factors and their correlation to tumor-associated proteolytic factors].
Harbeck N; Schüren E; Yamamoto N; Pache L; Schmitt M; Jänicke F; Dettmar P; Höfler H; Graeff H
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():303-4. PubMed ID: 8118325
[No Abstract] [Full Text] [Related]
29. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
30. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
31. Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer.
Feichter GE; Mueller A; Kaufmann M; Haag D; Born IA; Abel U; Klinga K; Kubli F; Goerttler K
Int J Cancer; 1988 Jun; 41(6):823-8. PubMed ID: 3372059
[TBL] [Abstract][Full Text] [Related]
32. A comparison between flow cytometric assessment of S-phase fraction and Nottingham histologic grade as prognostic instruments in breast cancer.
Sundquist M; Thorstenson S; Brudin L; Stål O; Nordenskjöld B
Breast Cancer Res Treat; 2000 Sep; 63(1):11-5. PubMed ID: 11079154
[TBL] [Abstract][Full Text] [Related]
33. Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: results from the Multicenter Morphometric Mammary Carcinoma Project (MMMCP).
Bergers E; Baak JP; van Diest PJ; van Gorp LH; Kwee WS; Los J; Peterse HL; Ruitenberg HM; Schapers RF; Somsen JG; van Beek MW; Bellot SM; Fijnheer J
Int J Cancer; 1997 Jun; 74(3):260-9. PubMed ID: 9221802
[TBL] [Abstract][Full Text] [Related]
34. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer].
Winter K; Eidtmann H; Jonat W
Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometric analysis of DNA ploidy and S-phase fraction in breast cancer using cells obtained by ex vivo fine-needle aspiration: an optimal method for sample collection.
Eliasen CA; Opitz LM; Vamvakas EC; Espiritu EC; Marsh ER; Roses DF; Harris MN; Feiner HD
Mod Pathol; 1991 Mar; 4(2):196-200. PubMed ID: 2047382
[TBL] [Abstract][Full Text] [Related]
37. Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens.
Bagwell CB; Clark GM; Spyratos F; Chassevent A; Bendahl PO; Stål O; Killander D; Jourdan ML; Romain S; Hunsberger B; Baldetorp B
Cytometry; 2001 Jun; 46(3):121-35. PubMed ID: 11449403
[TBL] [Abstract][Full Text] [Related]
38. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cell proliferation in breast carcinoma. Comparison of Ki-67 immunohistochemical study, DNA flow cytometric analysis, and mitotic count.
Isola JJ; Helin HJ; Helle MJ; Kallioniemi OP
Cancer; 1990 Mar; 65(5):1180-4. PubMed ID: 2406010
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]